These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 27725316)

  • 1. Microscale mechanical and mineral heterogeneity of human cortical bone governs osteoclast activity.
    Pernelle K; Imbert L; Bosser C; Auregan JC; Cruel M; Ogier A; Jurdic P; Hoc T
    Bone; 2017 Jan; 94():42-49. PubMed ID: 27725316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Foreign Body Giant Cell Cannot Resorb Bone, But Dissolves Hydroxyapatite Like Osteoclasts.
    ten Harkel B; Schoenmaker T; Picavet DI; Davison NL; de Vries TJ; Everts V
    PLoS One; 2015; 10(10):e0139564. PubMed ID: 26426806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone.
    Dodds RA; Connor JR; James IE; Rykaczewski EL; Appelbaum E; Dul E; Gowen M
    J Bone Miner Res; 1995 Nov; 10(11):1666-80. PubMed ID: 8592943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclast features of cells that resorb demineralized and mineral-containing bone implants in rats.
    Bagi CM; Miller SC
    Scanning Microsc; 1989 Sep; 3(3):963-8; discussion 969-70. PubMed ID: 2617274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of osteoclastogenesis and resorption activity of human osteoclasts on tissue culture polystyrene and on natural extracellular bone matrix in 2D and 3D.
    Kleinhans C; Schmid FF; Schmid FV; Kluger PJ
    J Biotechnol; 2015 Jul; 205():101-10. PubMed ID: 25562421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scanning electrochemical microscopy at the surface of bone-resorbing osteoclasts: evidence for steady-state disposal and intracellular functional compartmentalization of calcium.
    Berger CE; Rathod H; Gillespie JI; Horrocks BR; Datta HK
    J Bone Miner Res; 2001 Nov; 16(11):2092-102. PubMed ID: 11697806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in osteoclast biology and pathological bone resorption.
    Blair HC; Athanasou NA
    Histol Histopathol; 2004 Jan; 19(1):189-99. PubMed ID: 14702187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional role of osteopontin in directing intrafibrillar mineralization of collagen and activation of osteoclasts.
    Rodriguez DE; Thula-Mata T; Toro EJ; Yeh YW; Holt C; Holliday LS; Gower LB
    Acta Biomater; 2014 Jan; 10(1):494-507. PubMed ID: 24140612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation.
    Thudium CS; Moscatelli I; Flores C; Thomsen JS; Brüel A; Gudmann NS; Hauge EM; Karsdal MA; Richter J; Henriksen K
    Calcif Tissue Int; 2014 Jul; 95(1):83-93. PubMed ID: 24838599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.
    Henriksen K; Sørensen MG; Nielsen RH; Gram J; Schaller S; Dziegiel MH; Everts V; Bollerslev J; Karsdal MA
    J Bone Miner Res; 2006 Jan; 21(1):58-66. PubMed ID: 16355274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.
    Mizoguchi F; Izu Y; Hayata T; Hemmi H; Nakashima K; Nakamura T; Kato S; Miyasaka N; Ezura Y; Noda M
    J Cell Biochem; 2010 Apr; 109(5):866-75. PubMed ID: 20039311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lycopene I--effect on osteoclasts: lycopene inhibits basal and parathyroid hormone-stimulated osteoclast formation and mineral resorption mediated by reactive oxygen species in rat bone marrow cultures.
    Rao LG; Krishnadev N; Banasikowska K; Rao AV
    J Med Food; 2003; 6(2):69-78. PubMed ID: 12935316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of bone mineral-resembling biomaterials for optimizing human osteoclast differentiation and resorption.
    Nakamura M; Hentunen T; Salonen J; Nagai A; Yamashita K
    J Biomed Mater Res A; 2013 Nov; 101(11):3141-51. PubMed ID: 23554241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts.
    Vaes G
    Clin Orthop Relat Res; 1988 Jun; (231):239-71. PubMed ID: 3286076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
    Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
    Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone.
    Dai XM; Zong XH; Akhter MP; Stanley ER
    J Bone Miner Res; 2004 Sep; 19(9):1441-51. PubMed ID: 15312244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study.
    Taylor JC; Cuff SE; Leger JP; Morra A; Anderson GI
    Int J Oral Maxillofac Implants; 2002; 17(3):321-30. PubMed ID: 12074446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific antagonists of NMDA receptors prevent osteoclast sealing zone formation required for bone resorption.
    Itzstein C; Espinosa L; Delmas PD; Chenu C
    Biochem Biophys Res Commun; 2000 Feb; 268(1):201-9. PubMed ID: 10652236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.